FDA Aims To Be 'Nimble' On COVID-19 Vaccine Changes For Variants

By Sydney Lupkin
Published February 11, 2021 at 6:16 AM CST
  • Twitter
  • LinkedIn
  • Email
  • Twitter
  • LinkedIn
  • Email
Sydney Lupkin
Sydney Lupkin is the pharmaceuticals correspondent for NPR.
See stories by Sydney Lupkin